ClinicalTrials.Veeva

Menu

Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy

U

Universitair Ziekenhuis Brussel

Status

Unknown

Conditions

Breast Cancer Lymphedema
Cancer-related Pain
Autonomic Nervous System Imbalance
Quality of Life
Psychological Distress

Treatments

Other: Placebo
Device: Andullation

Study type

Interventional

Funder types

Other

Identifiers

NCT04125953
2018/455

Details and patient eligibility

About

The aim of this research is to study the influence of stochastic modulated vibrations on the autonomic nervous system of breast cancer patients during radiation therapy

Full description

Since it is well known that breast cancer patients experience an important load of stress from diagnosis through treatment and throughout cancer survivorship (fear of cancer recurrence), this study focusses on activation the parasympathetic nervous system and making patients as comfortable as possible during treatment. The scope of this study is based on previous research, that has shown that controlling physical and psychological complications during treatment may have a positive (preventive) effect on late term and long-term quality of life and survival outcomes. Breast cancer patients will receive andullation during their irradiation period. The primary outcome measure of the autonomic nervous system is vagal nerve activity, a modulator of the parasympathetic nervous system. Secondary outcome measures are stress, pain and lymphedema.

Enrollment

130 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histological proven breast cancer, following breast cancer surgery
  • Starting with adjuvant radiation therapy for 3 weeks
  • Minimum 18 years
  • Medical record available and complete
  • Supine lying on mattress for 20 minutes is possible
  • Dutch, French or English

Exclusion criteria

  • Severe neurological, orthopaedic or rheumatic disorders
  • Cardiac disorders
  • Early or synchronous malignancy
  • Pregnancy or lactation
  • Persons suffering from depression or illnesses which influence the mental health or wellbeing

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

130 participants in 2 patient groups, including a placebo group

Intervention
Experimental group
Description:
A 3 week intervention with Andullation will be performed, 3 times a week for 20 minutes after completion of the radiotherapy session
Treatment:
Device: Andullation
Control
Placebo Comparator group
Description:
This group will follow the same intervention protocol, but without the application of the Andullation technology
Treatment:
Other: Placebo

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Nele Adriaenssens, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems